If you're interested in navigating the GLP-1 generic pathway, or in developing other complex generic drug products, save the dates for our fantastic lineup of FDA/CRCG scientific workshops in 2026
It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) agonists, along with Wegovy and Saxenda
Through its interaction with the enzyme glutathione reductase, it constantly shifts between its active and inactive form, ensuring a continuous defense against free radical scavenging
Advertisement This new information will help physicians and patients make an informed decision, but I dont think the physician will make their recommendation solely on this study alone, he says
What even was the so-called scientific reason amphetamines caused weight loss anyways
Our 2025 analysis highlighted the early behavioral impact of GLP-1s